COF group (n=95) | EOF group (n=106) | |
---|---|---|
Age, median (range), (years) | 62 (30–82) | 60 (33–80) |
BMI, median (range), (kg/m2) | 20.9 (13.8–33.0) | 20.4 (14.0–32.6) |
Presence of comorbidities, n (%) | ||
Diabetes mellitus | 7 (7) | 8 (7) |
Hypertension | 22 (23) | 22 (20) |
ASA score, n (%) | ||
1 | 33 (35) | 30 (28) |
2 | 31 (33) | 37 (35) |
3 | 30 (32) | 37 (35) |
4 | 1 (1) | 2 (2) |
Preoperative Hb, median (range), (g/dL) | 11.1 (8.2–15.0) | 11.6 (8.6–15.0) |
Preoperative Alb, median (range), (g/dL) | 4.0 (1.9–5.0) | 4.0 (2.0–4.7) |
Diagnosis, n (%) | ||
Ovarian cancer | 86 (91) | 94 (89) |
Tubal cancer | 4 (4) | 5 (5) |
Peritoneal cancer | 5 (5) | 7 (7) |
Clinical stage, n (%) | ||
I | 4 (4) | 6 (6) |
IIB | 12 (13) | 11 (10) |
IIIA | 5 (5) | 4 (4) |
IIIB | 7 (7) | 7 (7) |
IIIC | 44 (46) | 48 (45) |
IVA | 1 (1) | 4 (4) |
IVB | 22 (23) | 26 (25) |
Histology, n (%) | ||
Serous | 65 (68) | 71 (67) |
Clear cell | 12 (13) | 19 (18) |
Endometrioid | 11 (12) | 12 (11) |
Mucinous | 3 (3) | 1 (1) |
Others | 4 (4) | 3 (3) |